Skip to content
All-In with Chamath, Jason, Sacks & Friedberg

Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

All-In with Chamath, Jason, Sacks & Friedberg

Introducing Eli Lilly CEO Dave Ricks
0:00,0
10 min
0:00
2:00
4:00
0:00 15:00 30:00
1x

Introducing Eli Lilly CEO Dave Ricks

How Eli Lilly discovered the GLP-1 impact on weight loss, counterfeit products from China

GLP-1 pricing and capital allocation after a breakout pharma product

Why Biotech VC has plummeted, "patent hacking" in China

Dave's health regimen: good sleep, movement, healthy diet, social relationships, reading

Unexpected impacts of GLP-1s, helping with addictions, potential mental health use cases

Thoughts on RFK Jr, Big Pharma's influence on the media, how AI empowers patients

Impact of proposed NIH cuts, explaining the "PBM boogeyman", next major pharma breakthrough



Follow the besties

Follow on X

@theallinpod

Follow on Instagram

@theallinpod

Follow on TikTok

@theallinpod

Follow on LinkedIn

linkedin.com/company/allinpod

Intro Music Credit

rb.gy/tppkzl

@yung_spielburg